Engineering next-generation, brain-penetrant cancer therapies.
Company is closed
Event Year: 2017
Company is closed
Event Year: 2017
Reverie Labs was focused on the development of innovative cancer therapies specifically designed to penetrate the blood-brain barrier. Their mission involved engineering next-generation treatments to address cancers affecting the brain. However, the company is no longer active.
Reverie Labs was focused on the development of innovative cancer therapies specifically designed to penetrate the blood-brain barrier. Their mission involved engineering next-generation treatments to address cancers affecting the brain. However, the company is no longer active.
Total Raised: Unknown (Y Combinator backed)
Last Round: Winter 2018
Total Raised: Unknown (Y Combinator backed)
Last Round: Winter 2018
Healthcare
Healthcare
Healthcare -> Therapeutics
Healthcare -> Therapeutics
Team size: 29
Hiring: No
Team size: 29
Hiring: No
